Alovudine

Alovudine (fluorothymidine) is an antiviral agent which was being developed by Medivir. It was discontinued after a Phase II trial in 2005 due to toxicity. It is a DNA polymerase inhibitor.[1]

Alovudine
Clinical data
Other namesFluorothymidine
ATC code
  • none
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC10H13FN2O4
Molar mass244.222 g·mol−1
3D model (JSmol)
 NY (what is this?)  (verify)

See also

References

  1. Georgopapadakou N (January 2007). "Discontinued drugs in 2005: anti-infectives". Expert Opinion on Investigational Drugs. 16 (1): 1–10. doi:10.1517/13543784.16.1.1. PMID 17155849. S2CID 24703317.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.